Finding 949051 (2023-004)

Material Weakness Repeat Finding
Requirement
P
Questioned Costs
-
Year
2023
Accepted
2024-03-06
Audit: 293672
Auditor: Mahoney

AI Summary

  • Core Issue: Inconsistent documentation in payroll files leads to potential inaccuracies in employee pay and benefits.
  • Impacted Requirements: Internal controls over payroll documentation are not being followed, violating Uniform Guidance and employee benefit plan audit standards.
  • Recommended Follow-Up: Implement new policies for maintaining personnel files, ensuring all pay rates, training, allocations, and evaluations are properly documented.

Finding Text

Finding 2023-004 – Lack of Documentation in Payroll Files Material Weakness Criteria – Management is responsible for establishing and maintaining internal controls over the payroll process, including maintaining proper documentation in personnel files. Uniform Guidance and the employee benefit plan audit specifically require adequate documentation of pay rates, benefit elections, time allocations, etc. to provide reasonable assurance that the amounts paid and deducted are accurate, allowable, and properly allocated. Condition – During our audit, we noted that pay rates for employees were not documented in a consistent, systematic manner. Additionally, we noted that there was missing evidence of recent training, program allocation documentation, and recent annual performance evaluations. Cause – The Organization’s policies and procedure around maintaining personnel file documentation were not followed by the Human Resources department. Context – The number of deviations noted below for personnel file testing are as follows: • Missing approved payrate letters for 4 of 7 employees selected. • 2 of 7 employee selected did not have recent training in their file. • 3 of the 7 employees did not have a program allocation documented in their file. • 4 of the 7 employees selected did not have recent performance evaluations. Effect – Effects could include: • Employees may be paid using an inappropriate rate or using a rate that is disputed by the employee or employer. • Salaries or wages may be overcharged or undercharged to grants if the proper program allocation is not documented. • Benefits due to employees may not be appropriately paid or deducted, violating applicable laws and/or regulations • Employees may not receive the proper training to execute program functions effectively. • Management cannot develop expectations or standards for the program if employee performance is not being reviewed timely. Recommendation – We recommend that the Organization implement policies and procedures around maintaining personnel files to ensure consistent and appropriate documentation for approvals of all pay rates, recent trainings, program allocations, and performance evaluations in individual personnel files to ensure that all wage rate approvals are documented in employee personnel files, recent training documentation is maintained, approved program allocations are documented, performance evaluations are performed and documented and proper benefits are paid or deducted. Auditee's comments and response – Management has reviewed the current practice for approval of raises and are implementing a new payroll system that will have authorizations built into the software which will correct this issue. Responsible party for corrective action: Laura Straw, Director of Finance and Morcine Scott-Warren, Deputy Director of HR and Dei. Repeat Finding: Yes, 2022-003

Categories

Allowable Costs / Cost Principles Material Weakness

Other Findings in this Audit

  • 372584 2023-001
    Material Weakness Repeat
  • 372585 2023-001
    Material Weakness Repeat
  • 372586 2023-001
    Material Weakness Repeat
  • 372587 2023-001
    Material Weakness Repeat
  • 372588 2023-001
    Material Weakness Repeat
  • 372589 2023-001
    Material Weakness Repeat
  • 372590 2023-001
    Material Weakness Repeat
  • 372591 2023-001
    Material Weakness Repeat
  • 372592 2023-002
    Significant Deficiency
  • 372593 2023-002
    Significant Deficiency
  • 372594 2023-002
    Significant Deficiency
  • 372595 2023-002
    Significant Deficiency
  • 372596 2023-002
    Significant Deficiency
  • 372597 2023-002
    Significant Deficiency
  • 372598 2023-002
    Significant Deficiency
  • 372599 2023-002
    Significant Deficiency
  • 372600 2023-003
    Significant Deficiency
  • 372601 2023-003
    Significant Deficiency
  • 372602 2023-003
    Significant Deficiency
  • 372603 2023-003
    Significant Deficiency
  • 372604 2023-003
    Significant Deficiency
  • 372605 2023-003
    Significant Deficiency
  • 372606 2023-003
    Significant Deficiency
  • 372607 2023-003
    Significant Deficiency
  • 372608 2023-004
    Material Weakness Repeat
  • 372609 2023-004
    Material Weakness Repeat
  • 372610 2023-004
    Material Weakness Repeat
  • 372611 2023-004
    Material Weakness Repeat
  • 372612 2023-004
    Material Weakness Repeat
  • 372613 2023-004
    Material Weakness Repeat
  • 372614 2023-004
    Material Weakness Repeat
  • 372615 2023-004
    Material Weakness Repeat
  • 372616 2023-005
    Significant Deficiency Repeat
  • 372617 2023-005
    Significant Deficiency Repeat
  • 372618 2023-005
    Significant Deficiency Repeat
  • 372619 2023-005
    Significant Deficiency Repeat
  • 372620 2023-005
    Significant Deficiency Repeat
  • 372621 2023-006
    Significant Deficiency
  • 372622 2023-006
    Significant Deficiency
  • 372623 2023-006
    Significant Deficiency
  • 372624 2023-006
    Significant Deficiency
  • 372625 2023-006
    Significant Deficiency
  • 949026 2023-001
    Material Weakness Repeat
  • 949027 2023-001
    Material Weakness Repeat
  • 949028 2023-001
    Material Weakness Repeat
  • 949029 2023-001
    Material Weakness Repeat
  • 949030 2023-001
    Material Weakness Repeat
  • 949031 2023-001
    Material Weakness Repeat
  • 949032 2023-001
    Material Weakness Repeat
  • 949033 2023-001
    Material Weakness Repeat
  • 949034 2023-002
    Significant Deficiency
  • 949035 2023-002
    Significant Deficiency
  • 949036 2023-002
    Significant Deficiency
  • 949037 2023-002
    Significant Deficiency
  • 949038 2023-002
    Significant Deficiency
  • 949039 2023-002
    Significant Deficiency
  • 949040 2023-002
    Significant Deficiency
  • 949041 2023-002
    Significant Deficiency
  • 949042 2023-003
    Significant Deficiency
  • 949043 2023-003
    Significant Deficiency
  • 949044 2023-003
    Significant Deficiency
  • 949045 2023-003
    Significant Deficiency
  • 949046 2023-003
    Significant Deficiency
  • 949047 2023-003
    Significant Deficiency
  • 949048 2023-003
    Significant Deficiency
  • 949049 2023-003
    Significant Deficiency
  • 949050 2023-004
    Material Weakness Repeat
  • 949052 2023-004
    Material Weakness Repeat
  • 949053 2023-004
    Material Weakness Repeat
  • 949054 2023-004
    Material Weakness Repeat
  • 949055 2023-004
    Material Weakness Repeat
  • 949056 2023-004
    Material Weakness Repeat
  • 949057 2023-004
    Material Weakness Repeat
  • 949058 2023-005
    Significant Deficiency Repeat
  • 949059 2023-005
    Significant Deficiency Repeat
  • 949060 2023-005
    Significant Deficiency Repeat
  • 949061 2023-005
    Significant Deficiency Repeat
  • 949062 2023-005
    Significant Deficiency Repeat
  • 949063 2023-006
    Significant Deficiency
  • 949064 2023-006
    Significant Deficiency
  • 949065 2023-006
    Significant Deficiency
  • 949066 2023-006
    Significant Deficiency
  • 949067 2023-006
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
14.267 Continuum of Care Program $326,522
14.231 Emergency Solutions Grant Program $118,642